Skip to content
healthcare.dev

Claritin Reditabs

NDC 11523-4329, Loratadine, tablet, orally disintegrating, from Bayer Healthcare LLC..

Product NDC
11523-4329
Status
Listed
Labeler
Bayer Healthcare LLC.
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
NDA
Application
NDA020704
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/11523-4329 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LORATADINE10 mg/1
Package NDCNDC-11Package
11523-4329-1115234329012 CARTON in 1 PACKAGE, COMBINATION (11523-4329-1) / 3 BLISTER PACK in 1 CARTON / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
11523-4329-2115234329026 BLISTER PACK in 1 CARTON (11523-4329-2) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 11523-4329 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/11523-4329 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 11523-4329. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.